Tech Company Financing Transactions
TAE Life Sciences Funding Round
TAE Life Sciences, based in Foothill Ranch, secured $30 million in funding from ARTIS Ventures.
Transaction Overview
Company Name
Announced On
6/4/2020
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series B
Investors
ARTIS Ventures (Stuart Peterson)
Proceeds Purpose
The company intends to use the funds to continue to move beyond the current boron-10 drug, BPA, and speed development of novel proprietary boron-10 target drugs at the same time that it hones its neutron beam accelerator technology for BNCT.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
19641 Da Vinci
Foothill Ranch, CA 92610
USA
Foothill Ranch, CA 92610
USA
Phone
Undisclosed
Website
Email Address
Overview
At TAE Life Sciences, our mission is to advance BNCT and investigate its potential as a promising treatment for broad clinical use. The foundation of our revolutionary pathway to treatment is an accelerator-based neutron beam, derived from decades of groundbreaking work by TAE Technologies, Inc., an innovative leader in fusion energy technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bruce Bauer
Chief Operating Officer
Robert Hill
Chief Scientific Officer
Kendall Morrison
VP - Bus. Development
Barry Bonner
VP - Bus. Development
Arnold Dijkstra
VP - Product Management
Anna Theriault
VP - Regulatory Affairs
Robert Kirby
Browse more venture capital transactions:
Prev: 6/4/2020: Pairin venture capital transaction
Next: 6/4/2020: Varo Money venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. All VC database entries on this site come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs